Clinical Trial Update: Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

View source ↗

Summary

Clinical trial NCT06964685 is evaluating adherence to Impella best-practice protocols in patients with acute myocardial infarction complicated by cardiogenic sh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction with Cardiogenic Shock

Drugs mentioned

• Impella (Impella microaxial pump)

Snippet

Sponsor: Abiomed Inc. | Conditions: AMI Cardiogenic Shock | Status: RECRUITING